Related Experiment Video
Updated: May 27, 2025
Analysis of Microglia and Monocyte-derived Macrophages from the Central Nervous System by Flow Cytometry
Published on: June 22, 2017
Comparative Analysis of HMC3 and C20 Microglial Cell Lines Reveals Differential Myeloid Characteristics and Responses
Bavani Gunasegaran1, Shivani Krishnamurthy1, Sharron S Chow1
1Macquarie Medical School, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, New South Wales, Australia.
Abstract:
Microglia are the primary resident immune cells of the central nervous system (CNS) that respond to injury and infections. Being critical to CNS homeostasis, microglia also have been shown to contribute to neurodegenerative diseases and brain cancer. Hence, microglia are regarded as a potential therapeutic target in CNS diseases, resulting in an increased demand for reliable in vitro models. Two human microglia cell lines (HMC3 and C20) are being used in multiple in vitro studies, however, the knowledge of their biological and immunological characteristics remains limited. Our aim was to identify and compare the biological changes in these immortalised immune cells under normal physiological and immunologically challenged conditions. Using high-resolution quantitative mass spectrometry, we have examined in-depth proteomic profiles of non-stimulated and LPS or IFN-γ challenged HMC3 and C20 cells. Our findings reveal that HMC3 cells responded to both treatments through upregulation of immune, metabolic, and antiviral pathways, while C20 cells showed a response associated with mitochondrial and immune activities. Additionally, the secretome analysis demonstrated that both cell lines release IL-6 in response to LPS, while IFN-γ treatment resulted in altered kynurenine pathway activity, highlighting distinct immune and metabolic adaptations.
Insights
This study compares two human microglia cell lines (HMC3 and C20) for in vitro research. HMC3 cells show robust immune responses, while C20 cells exhibit mitochondrial and immune activity changes.
Area of Science:
- Neuroscience
- Immunology
- Cell Biology
Background:
- Microglia are crucial immune cells in the central nervous system (CNS), involved in homeostasis and disease.
- Their role in neurodegenerative diseases and brain cancer makes them a therapeutic target.
- Reliable in vitro models are needed, but the characteristics of human microglia cell lines (HMC3, C20) are not fully understood.
Purpose of the Study:
- To compare the biological and immunological characteristics of HMC3 and C20 human microglia cell lines.
- To investigate their responses under normal physiological and immune-challenged conditions.
Main Methods:
- High-resolution quantitative mass spectrometry was used to analyze proteomic profiles.
- Non-stimulated and lipopolysaccharide (LPS) or interferon-gamma (IFN-γ) challenged HMC3 and C20 cells were examined.
- Secretome analysis was performed to assess released factors.
Main Results:
- HMC3 cells upregulated immune, metabolic, and antiviral pathways upon LPS or IFN-γ challenge.
- C20 cells demonstrated responses linked to mitochondrial and immune activities.
- Both cell lines released IL-6 in response to LPS; IFN-γ altered kynurenine pathway activity in both.
Conclusions:
- HMC3 and C20 cells exhibit distinct proteomic and secretome profiles and immune responses.
- These findings highlight unique immune and metabolic adaptations in each cell line.
- The study provides valuable insights for selecting appropriate human microglia cell lines for in vitro CNS research.
